Omayma O Abdelaleem

Years Active: 2018-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Marwa A Ali, Olfat G Shaker, Eman M Ezzat, Hanaa M Eid, Doaa Y Ali, Essam A Hassan, Dalia H Elsayed, Eman R Abozaid, Omayma O Abdelaleem
Serum lncRNAs, NBAT-1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C. Molecular carcinogenesis (2022)
Omayma O Abdelaleem, Shereen Rashad Mohammed, Hassan S El Sayed, Sherin Khamis Hussein, Doaa Y Ali, Mostafa Y Abdelwahed, Sylvana N Gaber, Nada F Hemeda, Rehab G Abd El-Hmid
Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis. PloS one 17 (1) (2022)
Omayma O Abdelaleem, Nermeen A Fouad, Olfat G Shaker, Tarek I Ahmed, Noha K Abdelghaffar, Hanaa M Eid, Abdelrahmaan A Mohamed, Ahmed Magdy Elebiary, Mohamed M Mohamed, Rania H Mahmoud
Serum miR-224, miR-760, miR-483-5p, miR-378 and miR-375 as potential novel biomarkers in rheumatoid arthritis. International journal of clinical practice 75 (11) (2021)
Olfat Gamil Shaker, Omayma O Abdelaleem, Rania H Mahmoud, Noha K Abdelghaffar, Tarek I Ahmed, Omar M Said, Othman M Zaki
Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy. IUBMB life 71 (3) (2018)

Omayma O Abdelaleem.css-eqlu8i{font-size:small;padding-left:4px;}